statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for year 2016 ended December 31, 2016. The Company’s overall
statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for year 2016 ended December 31, 2016. The Company’s overall
31, 2018. Such financial statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for the first quarter of the year
, 2018. Such financial statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for the first half of the year 2017 ended
ended September 30, 2018. Such financial statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for the same period in
incomes, other significant incomes must be displayed in a separate row (if any). Give a separate description of each product line or business group in the following matters. 2 Disclosure is not required if
equity method. 3 Describe the nature and proportion of other incomes, other significant incomes must be displayed in a separate row (if any). Give a separate description of each product line or business
: Million Baht) Consolidated Separate Y2017 + Increased /-Decreased Y2017 + Increased /-Decreased Brokerage fees income 592.30 (28.82) 592.30 (28.82) Fees and service income 38.75 (16.45) 38.75 (16.45
previous year 7.62%. Income from medical treatments in the separate financial statement went up 4.79% due to the increased in the number of out-patients to 2.57% but the decreased in the number of in
U City Public Company Limited (Registration No. 0107537000459) 21 TST Tower Soi Choei Phuang, Viphavadi-Rangsit Road, Chomphon, Chatuchak, Bangkok 10900, Thailand T: + 662 273 8838 F: + 662 273 8858 www.ucity.co.th Ref. No. U.SET 019/2017 October 30, 2017 Subject: Entire business transfer of Unicorn Enterprise Company Limited, capital increase, issuance of the U-W3 Warrants and U-W4 Warrants, issuance and offering of the newly issued preferred shares to be issued and offered to the existing shar...